H1N1sw Vaccine in Adult Transplant Recipients

Summary

The trial investigates the efficacy of the adjuvanted H1N1 influenza vaccine Focetria(R) in immunocompromised adults who have undergone solid organ or bone marrow transplantation. It is expected that when administered twice the vaccine fulfills all serological efficacy criteria required for the elderly population age 60 years and older.

Timeline

Start

2010-02

Primary completion

2011-04

Completion

2012-04

Drugs

Indications